Search Results for: ulcerative colitis

January 10, 2020January 10, 2020

Prevalence of Ulcerative Colitis in the US Remains Stable at 1%, Survey Data Show

News

The prevalence of ulcerative colitis remained stable in the United States from 1976 to 2010, affecting 1% of the population, according to a survey analysis. The study also found that ... Read more

January 6, 2020January 7, 2020

UK Regulatory Agency Approves Launch of Innovation’s Phase 1 Trial of Brilacidin for Ulcerative Colitis

News

The United Kingdom’s Medicines and Healthcare products Regulatory Agency has approved the launch of Innovation Pharmaceuticals’ Phase 1 trial in healthy volunteers to investigate the safety and properties of delayed-release ... Read more

December 18, 2019December 18, 2019

FDA Approves Extended-Release Xeljanz for Adults with Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Pfizer‘s extended-release tablets of Xeljanz XR (tofacitinib) to treat adults with moderately to severely active ulcerative colitis. This approval of 11 mg ... Read more

December 16, 2019December 16, 2019

FDA Approves Avsola, Remicade Biosimilar, to Treat Crohn’s Disease and Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Amgen’s Avsola (infliximab-axxq) — a biosimilar to Janssen’s Remicade (infliximab) — to treat adults and children with moderate-to-severe Crohn’s disease (CD) ... Read more

December 2, 2019December 2, 2019

Abivax’s Phase 2b Trial Testing ABX464 for Ulcerative Colitis Cleared to Add French Sites

News

France’s National Agency for the Safety of Medicine and Health Products (ANSM) has cleared the inclusion of French study sites for Abivax‘s new Phase 2b clinical trial, intended to evaluate ... Read more

October 25, 2019October 25, 2019

One-year Data Support Efficacy and Safety of Abivax’s ABX464 for Ulcerative Colitis

News

Abivax has announced data from a long-term trial that continues to support the efficacy and safety of its investigational oral treatment ABX464 for ulcerative colitis (UC). One year of treatment ... Read more

October 22, 2019October 22, 2019

Stelara Approved in US to Treat Moderate-to-Severe Ulcerative Colitis

News

The U.S. Food and Drug Administration (FDA) has approved Stelara (ustekinumab) for the treatment of adults with ulcerative colitis (UC) that is moderately to severely active, Janssen Pharmaceuticals, Stelara’s developer and ... Read more

October 17, 2019October 15, 2019

Reading the Fine Print: Discovering I Have Ulcerative Colitis

Columns, Intestinal Fortitude - a Column by Emmeline Olson

I was purging paperwork the other day when I came across follow-up notes from my last gastroenterologist appointment. I never read these notes when I check out. I usually only ... Read more

October 9, 2019October 9, 2019

Interim Analysis Suggests Wider-than-expected Dosing Range for IMU-838 to Treat Ulcerative Colitis

News

Interim analysis of a Phase 2 clinical trial that’s investigating IMU-838 in people with ulcerative colitis (UC) suggests a broader dose range than initially anticipated, announced the therapy’s developer, Immunic ... Read more

September 20, 2019September 20, 2019

Innovation Pharma Planning 1st Clinical Trial of Oral Brilacidin as Potential Ulcerative Colitis Treatment

News

Innovation Pharmaceuticals is planning a first clinical trial of an oral formulation of Brilacidin as a treatment for ulcerative colitis (UC), one of the most common types of inflammatory bowel disease (IBD). Brilacidin ... Read more